Corporate Information

Leaders

The Remedy Group, with its abundance in expertise and experience in all areas of drug development, will provide 360 degrees of support for your drug development needs.
Our consulting services goes beyond typical drug development with - global drug development across Asia in all therapeutic areas, Remedy Group’s advanced know-how, and unmatched knowledge in oncology and regenerative medicine.

Life Sciences Consulting

Delivering innovative new drugs and the latest medical devices to patients as quickly as possible.

Masashi Iwasaki

Background as a Consultant

  • Twenty (20) years of experience in drug development in pharmaceutical companies
  • The Clinical Evaluation Expert Committee of Japan Pharmaceutical Manufacturers Association (JPMA), and representative members of preparing the guideline of ICH-E11 in Promoting Pediatric Drug Development
  • Nine (9) years of experience in clinical trial support from establishment of SMO facility
  • Former Board Member, Japan Association of Site Management Organizations
  • More than 10 years of experience in drug and medical device development at CRO

Global Development

Pharmaceutical Development Partners without Borders

Tomoko Eguchi

Background as a Consultant

  • Twenty (20) years of pharmaceutical and medical device development experiences in CRO
  • Planning and conduct from clinical trials to PMS in Japan
  • Development consultants and project management services in East Asia (China, Korea, and Taiwan) and Southeast Asia
  • Development and introduction consultation of clinical trials related systems such as EDC/IWRS
  • Japanese (Native), English (Business), Korean (Business)

Oncology

We Provide Strong Support for Oncology Development.

Masahiko Sakamoto

Background as a Consultant

  • Over 17 years of experience in development related work for foreign pharmaceutical company
  • Over 12 years of experience in development related works with CRO
  • Over 15 years of development experience in the oncology field, with a focus on Global Phase III experience.
  • Experienced Oncology Areas
    • Breast cancer, Colorectal cancer, NSCLC, Stomach cancer, Ovarian cancer, NHL
  • Work Experience as a Consultant
    • Developmental strategies for Phase I studies, Feasibility surveys, Strategy to prevent delays in in-patients, Protocols/ICF reviews, developmental strategies in Japan for foreign venture companies and research with KOL for developmental strategies and markets.
  • Experience for Inspection
    • Preparation for FDA and EMA inspections, attending and responding to inspections for a week at each site.
    • Attending and responding to inspections for PMDA 5 times.

Regenerative Medicine

Platform for Regenerative Medicine Development.

Shinji Yamamoto

Background as a Consultant

  • Ten (10) years of experience in basic research of regenerative medicine in academia
  • Seven (7) years of experience in Non-clinical drug development in pharmaceutical companies
  • Four (4) years of experience in drug development in CRO